CpG 7909, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Treatment
This study is currently recruiting participants.
Study NCT00438880
Information provided by National Cancer Institute (NCI)
First Received: February 20, 2007
Last Updated: October 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
